USANA Health Sciences USNA Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by USANA Health Sciences in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.
The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about USANA Health Sciences's additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is USANA Health Sciences's additional paid-in capital?
- USANA Health Sciences (USNA) reported additional paid-in capital of $84.73M in Q1 2026.
- How has USANA Health Sciences's additional paid-in capital changed year-over-year?
- USANA Health Sciences's additional paid-in capital increased by 13.2% year-over-year, from $74.87M to $84.73M.
- What is the long-term trend for USANA Health Sciences's additional paid-in capital?
- Over 5 years (2020 to 2025), USANA Health Sciences's additional paid-in capital has grown at a 6.0% compound annual growth rate (CAGR), from $62.46M to $83.54M.
- What does additional paid-in capital mean?
- This represents the excess amount paid by investors for common shares over their par value. It is a key component of shareholders' equity that captures the capital raised through equity offerings beyond the nominal value of the stock. It reflects the historical market premium at which the company has issued its shares.